| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 3, 2023 | UTHR United Therapeutics Corp | Mahon Paul A47 | EVP &General Counsel | Sell | 6,000 | $236.25 | $1,417,470.05 | -2.2% | -3.4% | +41.3% | |
| Aug 2, 2023 | MIRA Mira Pharmaceuticals, Inc. | Cappy George | - | Buy | 157,170 | $7.00 | $1,100,190.00 | +6.1% | -73.9% | -67.3% | |
| Aug 2, 2023 | PCRX Pacira Biosciences, Inc. | Winston Roy68 | Chief Medical Officer | Sell | 509 | $34.88 | $17,751.38 | -1.0% | -23.0% | -43.5% | |
| Aug 2, 2023 | MRK Merck & Co., Inc. | Romanelli Joseph57 | President, Human Health Int?l | Sell | 89 | $107.37 | $9,556.02 | -0.4% | -2.2% | +10.6% | |
| Aug 1, 2023 | TEVA Teva Pharmaceutical Industries Ltd | Hughes Eric A | See "remarks" | Sell | 52,742 | $8.30 | $437,690.04 | -100% | +3.1% | +110.3% | |
| Aug 1, 2023 | ANIP Ani Pharmaceuticals Inc | Gassert Chad60 | SVP - Corp. Dev. &Strategy | Sell | 20,000 | $51.06 | $1,021,200.00 | -5.7% | +19.1% | +29.4% | |
| Jul 26, 2023 | JNJ Johnson & Johnson | Hait William65 | See Remarks | Sell | 14,698 | $172.00 | $2,528,056.00 | -14.3% | -12.4% | -7.6% | |
| Jul 25, 2023 | KNSA Kiniksa Pharmaceuticals International, Plc | Paolini John F.51 | Chief Medical Officer | Sell | 29,000 | $19.14 | $555,160.08 | -15.6% | -21.7% | +29.4% | |
| Jul 25, 2023 | JNJ Johnson & Johnson | Fasolo Peter61 | Exec VP, Chief Hr Officer | Sell | 20,000 | $170.32 | $3,406,498.00 | -16.3% | -12.2% | -9.3% | |
| Jul 24, 2023 | DERM Journey Medical Corp | Maraoui Claude | President &CEO | Sell | 20,767 | $1.76 | $36,549.92 | -1.0% | +80.6% | +200.6% | |
| Jul 24, 2023 | DERM Journey Medical Corp | Benesch Joseph | See Remarks | Sell | 4,072 | $1.76 | $7,166.72 | -6.1% | +80.6% | +200.6% | |
| Jul 21, 2023 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 591 | $466.62 | $275,773.01 | - | +27.9% | +85.6% | |
| Jul 21, 2023 | ANIP Ani Pharmaceuticals Inc | Shanmugam Muthusamy59 | Head Of R&D, Coo-novitium Ops | Sell | 23,469 | $52.02 | $1,220,844.12 | -0.6% | +9.8% | +19.2% | |
| Jul 20, 2023 | UTHR United Therapeutics Corp | Mahon Paul A47 | EVP &General Counsel | Sell | 2,500 | $243.87 | $609,675.00 | -6.4% | -5.7% | +34.7% | |
| Jul 20, 2023 | ETST Earth Science Tech, Inc. | Saumat Giorgio R. | CEO | Buy | 10,000 | $0.08 | $800.00 | - | - | - | |
| Jul 19, 2023 | LNTH Lantheus Holdings, Inc. | Sabens Andrea47 | Chief Accounting Officer | Sell | 1,752 | $90.87 | $159,209.50 | -2.8% | -17.8% | +29.7% | |
| Jul 19, 2023 | ESPR Esperion Therapeutics, Inc. | Warren Eric60 | Chief Commercial Officer | Sell | 106 | $1.59 | $168.01 | -0.2% | -38.8% | +59.1% | |
| Jul 19, 2023 | HIMS Hims & Hers Health, Inc. | Dudum Andrew48 | Chief Executive Officer | Sell | 88,269 | $9.11 | $804,137.63 | -100% | -28.8% | +129.1% | |
| Jul 19, 2023 | ETST Earth Science Tech, Inc. | Saumat Giorgio R. | CEO | Buy | 50,002 | $0.08 | $4,049.70 | - | - | - | |
| Jul 18, 2023 | ANIP Ani Pharmaceuticals Inc | Shanmugam Muthusamy59 | Head Of R&D, Coo-novitium Ops | Sell | 26,531 | $51.02 | $1,353,598.86 | -0.7% | +12.9% | +21.4% | |
| Jul 7, 2023 | ETST Earth Science Tech, Inc. | Saumat Giorgio R. | CEO | Buy | 3,000 | $0.05 | $150.00 | - | - | - | |
| Jul 6, 2023 | UTHR United Therapeutics Corp | Mahon Paul A47 | EVP &General Counsel | Sell | 6,000 | $215.19 | $1,291,165.31 | -3.9% | +4.2% | +47.7% | |
| Jul 6, 2023 | HIMS Hims & Hers Health, Inc. | Baird Melissa | Chief Operating Officer | Sell | 9,133 | $8.68 | $79,282.66 | -2.0% | -28.3% | +140.2% | |
| Jul 5, 2023 | PCRX Pacira Biosciences, Inc. | Riker Lauren Bullaro76 | Senior Vice President, Finance | Sell | 643 | $38.91 | $25,019.13 | -2.8% | -24.7% | -45.7% | |
| Jul 5, 2023 | HIMS Hims & Hers Health, Inc. | Baird Melissa | Chief Operating Officer | Sell | 18,266 | $9.03 | $165,008.65 | -2.0% | -30.1% | +133.7% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.